SERA PROGNOSTICS, INC. (SERA) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $4.00K; Additional Paid in Capital, Common StockUSD (m); Additional Paid in CapitalUSD $388.68M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-48.00K.
- 2026-03-31: Common Stock, Value, IssuedUSD $4.00K; Additional Paid in Capital, Common StockUSD (m); Additional Paid in CapitalUSD $387.72M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $16.00K.
- 2025-12-31: Common Stock, Value, IssuedUSD $4.00K; Additional Paid in Capital, Common StockUSD (m); Additional Paid in CapitalUSD $386.86M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $262.00K.
- 2025-09-30: Common Stock, Value, IssuedUSD $4.00K; Additional Paid in Capital, Common StockUSD (m); Additional Paid in CapitalUSD $385.75M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $268.00K.
SERA PROGNOSTICS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.00K | (m) | $388.68M | $-48.00K | $-329.26M | $59.38M | 3 month · $823.00K | (m) |
| 2026-03-31 | $4.00K | (m) | $387.72M | $16.00K | $-320.12M | $67.62M | 3 month · $835.00K | (m) |
| 2025-12-31 | $4.00K | (m) | $386.86M | $262.00K | $-311.72M | $75.41M | 12 month · $5.11M | (m) |
| 2025-09-30 | $4.00K | (m) | $385.75M | $268.00K | $-303.84M | $82.18M | 3 month · $1.25M | (m) |
| 2025-06-30 | $4.00K | (m) | $384.10M | $145.00K | $-296.03M | $88.23M | 3 month · $1.34M | (m) |
| 2025-03-31 | $4.00K | (m) | $382.68M | $76.00K | $-287.98M | $94.78M | 3 month · $1.49M | (m) |
| 2024-12-31 | $3.00K | $327.53M | $327.53M | $60.00K | $-279.79M | $47.80M | 12 month · $7.01M | (m) |
| 2024-09-30 | $3.00K | (m) | $325.57M | $292.00K | $-271.21M | $54.65M | 3 month · $1.68M | (m) |
| 2024-06-30 | $3.00K | (m) | $323.26M | $-211.00K | $-263.30M | $59.75M | 3 month · $2.02M | (m) |
| 2024-03-31 | $3.00K | (m) | $319.92M | $-181.00K | $-254.99M | $64.75M | 3 month · $1.69M | (m) |
| 2023-12-31 | $3.00K | $317.07M | $317.07M | $-15.00K | $-246.90M | $70.16M | 12 month · $5.27M | (m) |
| 2023-09-30 | $3.00K | (m) | $314.99M | $-614.00K | $-238.97M | $75.41M | 3 month · $1.18M | (m) |
| 2023-06-30 | $3.00K | (m) | $313.57M | $-672.00K | $-231.76M | $81.14M | 3 month · $1.44M | (m) |
| 2023-03-31 | $3.00K | (m) | $311.88M | $-457.00K | $-221.22M | $90.21M | 3 month · $1.30M | (m) |
| 2022-12-31 | $3.00K | (m) | $310.57M | $-981.00K | $-210.65M | $98.94M | 12 month · $5.05M | (m) |
| 2022-09-30 | $3.00K | (m) | $309.23M | $-1.17M | $-200.91M | $107.16M | 3 month · $1.28M | (m) |
| 2022-06-30 | $3.00K | (m) | $307.92M | $-818.00K | $-190.20M | $116.91M | 3 month · $1.21M | (m) |
| 2022-03-31 | $3.00K | (m) | $306.53M | $-656.00K | $-178.68M | $127.20M | 3 month · $1.22M | (m) |
| 2021-12-31 | $3.00K | (m) | $305.21M | $-183.00K | $-166.47M | $138.56M | 12 month · $3.13M | 12 month · $1.07M |
| 2021-09-30 | $3.00K | (m) | $304.04M | $-25.00K | $-153.98M | $150.04M | 3 month · $914.00K | (m) |
| 2021-06-30 | (m) | (m) | $8.33M | (m) | $-144.12M | $-135.80M | 3 month · $864.00K | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | $-130.39M | 3 month · $239.00K | 3 month · $1.07M |
| 2020-12-31 | $0.00 | (m) | $5.89M | $0.00 | $-131.46M | $-125.57M | 12 month · $726.00K | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | $-120.49M | 3 month · $195.00K | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | $-115.69M | 3 month · $201.00K | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | $-111.18M | 3 month · $135.00K | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | $-106.62M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |